xDot Medical can begin FDA IDE study of vascular closure device
July 6, 2026
xDot Medical announced today that it received FDA investigational device exemption (IDE) approval for its access management system (AMS).
xDot Medical announced today that it received FDA investigational device exemption (IDE) approval for its access management system (AMS).
Movmedix announced today that it received FDA 510(k) clearance for its third-generation LARS ACJ synthetic ligament implant platform.
Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute and Heidelberg University Hospital (UKHD) have developed “HemaGuide,” an AI assistant that supports physicians in making difficult treatment decisions.
The Technical University of Munich (TUM) has developed a soft, pneumatic glove that restores the ability of people with paralyzed hands to grasp object
In recent years, notable advances have been made in diagnosing and treating breast cancer. However, its recurrence continues to plague thousands, deepening the need to find ways to better predict the likelihood of its return.
A paper published in the journal Biomarker Research by a cross-university team led by Queen Mary University of London researchers validates the use of a noninvasive brush biopsy test that can detect oral cancer within one hour.
A new artificial intelligence model called COMPASS, developed by Harvard Medical School researchers and their colleagues, improves prediction of which patients are most likely to respond to ICIs.
The CE marking by GMED recognises compliance with patient safety and clinical efficacy for Class IIb devices.
Visby’s multi-viral Medical Flu and Covid-19 test yields results in 30 minutes.
In a preprint published in bioRxiv, the team describes SpudCell. The system could grow, copy its DNA, divide, and take in fresh materials from smaller bubble-like structures nearby. When the team gave one version a genetic change that helped it feed more efficiently, those cells grew faster and became more common over five generations.